Daniel Hui

Daniel Hui is a seasoned expert in immunology and product characterization, currently serving as Senior Director at Asklepios BioPharmaceutical, Inc. since April 2022. Prior roles include Associate Director at Resilience for a brief period in early 2022 and significant contributions at Tmunity Therapeutics from March 2019 to December 2021 as Associate Director of Product Characterization and Clinical Assay Development, as well as Senior Scientist. Daniel was previously the Cell-based Assay Lead at Spark Therapeutics from October 2014 to February 2019, focusing on managing a team for monitoring immune responses in gene-transfer patients. Earlier experience includes a research scientist role at Spark Therapeutics and a postdoctoral fellowship at The Children's Hospital of Philadelphia. Daniel holds a Ph.D. in Molecular Virology from Case Western Reserve University School of Medicine and a B.S. in Microbiology from the University of Pittsburgh.